Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent
April 20, 2015 at 16:09 PM EDT
Pharmacyclics, Inc. (NASDAQ: PCYC) fell victim Monday to the latest patent challenge by hedge fund manager and short seller Kyle ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.